{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:30:03Z","timestamp":1781566203697,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Malabsorption of levothyroxine (LT4) is a common problem faced in clinical practice. It is usually solved, if there are no complexities including gastrointestinal absorption disorder, by taking medicines on an empty stomach and avoiding foods interfering with LT4. Herein we present a rare case of a patient exhibiting malabsorption of LT4 with decreased membranous expression of ileal transporters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case<\/jats:title><jats:p>The 22-Year-old female presented with sustained hypothyroid status despite medication of 7.8 \u03bcg\/kg LT4. Medical history and LT4 absorption test (the absorption rate 8.4%) excluded pseudomalabsorption. No organic gastrointestinal disorder was found in the patient by blood chemistry, endoscopies, and abdominal computed tomography scan. The immunohistochemical analysis showed decreased membranous expression of LAT1 and LAT2 in distal ileum and ascending colon in the patient compared to 20 controls who have no thyroid disease. The expression of MCT8 in colon appeared at both nucleus and brush border in the patient, while it was limited to brush border in controls. The expression of other transporters was similar between the patient and controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The changes of the expression of LAT1 and LAT2 in this patient showing LT4 malabsorption might help to understand the role of intestinal transporters in the absorption of LT4 in humans. The functional relevance of the decrement of LAT1 and LAT2 in this patient remains to be elucidated.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.664839","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T06:57:01Z","timestamp":1622012221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Decreased Expression of Ileal Thyroid Hormone Transporters in a Hypothyroid Patient: A Case Report"],"prefix":"10.3389","volume":"12","author":[{"given":"Chae Won","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyung Seo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Mo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2017.32.1.106","article-title":"Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015","volume":"32","author":"Won Gu","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (Nhanes Iii)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2409","article-title":"The Incidence and Prevalence of Thyroid Dysfunction in Europe: A Meta-Analysis","volume":"99","author":"Garmendia Madariaga","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-119-6-199309150-00009","article-title":"Levothyroxine Therapy in Patients With Thyroid-Disease","volume":"119","author":"Mandel","year":"1993","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343972","article-title":"Levothyroxine Therapy and Serum Free Thyroxine and Free Triiodothyronine Concentrations","volume":"25","author":"Woeber","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","journal-title":"Endocrine practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00233","article-title":"Ulcerative Colitis as a Novel Cause of Increased Need for Levothyroxine","volume":"10","author":"Virili","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00090","article-title":"Subclinical Hypothyroidism in Women Planning Conception and During Pregnancy: Who Should Be Treated and How","volume":"2","author":"Maraka","year":"2018","journal-title":"J Endocrine Soc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.3.386","article-title":"Update on the Management of Thyroid Disease During Pregnancy","volume":"31","author":"Yim","year":"2016","journal-title":"Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ph14030206","article-title":"Levothyroxine Interactions With Food and Dietary Supplements\u2013a Systematic Review","volume":"14","author":"Wiesner","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000452489","article-title":"Pseudomalabsorption of Levothyroxine: A Challenge for the Endocrinologist in the Treatment of Hypothyroidism","volume":"6","author":"Van Wilder","year":"2017","journal-title":"Eur Thyroid J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-14-4-401","article-title":"The Use and Misuse of Thyroid Hormone*","volume":"14","author":"Roti","year":"1993","journal-title":"Endocrine Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4158\/EP13487.OR","article-title":"The Clinical Utility of Free Thyroxine in Oral Levothyroxine Absorption Testing","volume":"20","author":"Sun","year":"2014","journal-title":"Endocr Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4158\/EP13316.CR","article-title":"Tablet Levothyroxine (L-T4) Malabsorption Induced by Proton Pump Inhibitor; a Problem That was Solved by Switching to L-T4 in Soft Gel Capsule","volume":"20","author":"Vita","year":"2014","journal-title":"Endocr Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31817ee556","article-title":"Isolated Thyroxine Malabsorption Treated With Intramuscular Thyroxine Injections","volume":"337","author":"Anderson","year":"2009","journal-title":"Am J Med Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4103\/2230-8210.95716","article-title":"A Curious Case of Refractory Hypothyroidism Due to Selective Malabsorption of Oral Thyroxine","volume":"16","author":"Damle","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.1047","article-title":"Impaired Enteral Levothyroxine Absorption in Hypothyroidism Refractory to Oral Therapy After Thyroid Ablation for Papillary Thyroid Cancer: Case Report and Kinetic Studies","volume":"16","author":"T\u00f6njes","year":"2006","journal-title":"Thyroid"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.4.0435","article-title":"Plasma Membrane Transport of Thyroid Hormones and its Role in Thyroid Hormone Metabolism and Bioavailability","volume":"22","author":"Hennemann","year":"2001","journal-title":"Endocr Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/me.2010-0095","article-title":"Minireview: Thyroid Hormone Transporters: The Knowns and the Unknowns","volume":"25","author":"Visser","year":"2011","journal-title":"Mol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00599-4","article-title":"Thyroid Hormone Transporters: Recent Advances","volume":"13","author":"Abe","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2007.03.004","article-title":"Cellular Entry of Thyroid Hormones by Organic Anion Transporting Polypeptides","volume":"21","author":"Hagenbuch","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1006\/bbrc.1998.9974","article-title":"Identification of Thyroid Hormone Transporters","volume":"254","author":"Friesema","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2007.03.002","article-title":"Tissue Uptake of Thyroid Hormone by Amino Acid Transporters","volume":"21","author":"Taylor","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1140","article-title":"Transport of Iodothyronines by Human L-Type Amino Acid Transporters","volume":"156","author":"Zevenbergen","year":"2015","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300909200","article-title":"Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone Transporter","volume":"278","author":"Friesema","year":"2003","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0112","article-title":"Effective Cellular Uptake and Efflux of Thyroid Hormone by Human Monocarboxylate Transporter 10","volume":"22","author":"Friesema","year":"2008","journal-title":"Mol Endocrinol (Baltimore Md)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.66","article-title":"Thyroid Hormone Transporters-Functions and Clinical Implications","volume":"11","author":"Bernal","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1991.1.241","article-title":"Localization of Human Thyroxine Absorption","volume":"1","author":"Hays","year":"1991","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0004563216642255","article-title":"Thyroxine Replacement: A Clinical Endocrinologist\u2019s Viewpoint","volume":"53","author":"Eligar","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-28-6-749","article-title":"Absorption of Oral Thyroxine in Man","volume":"28","author":"Hays","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","volume-title":"Non-Isotopic Method for Determination of Oral Thyroxine Absorption","author":"Greenstadt","year":"1982"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106835","article-title":"Simultaneous Measurement of Thyroxine and Triiodothyronine Peripheral Turnover Kinetics in Man","volume":"51","author":"Nicoloff","year":"1972","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-1035","article-title":"A Thyroxine Absorption Test Followed by Weekly Thyroxine Administration: A Method to Assess non-Adherence to Treatment","volume":"168","author":"Walker","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0256","article-title":"The Levothyroxine Absorption Test: A Four-Year Experience (2015\u20132018) At The Mayo Clinic","volume":"29","author":"Gonzales","year":"2019","journal-title":"Thyroid"},{"key":"B35","article-title":"Intestinal Absorption of Thyroid Hormone","volume":"87","author":"Kelderman-Bolk","year":"2015"},{"key":"B36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000381542","article-title":"Involvement of the L-Type Amino Acid Transporter Lat2 in the Transport of 3,3\u2032-Diiodothyronine Across the Plasma Membrane","volume":"4","author":"Kinne","year":"2015","journal-title":"Eur Thyroid J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.10.8418","article-title":"Thyroid Hormone Transport by the Heterodimeric Human System L Amino Acid Transporter","volume":"142","author":"Friesema","year":"2001","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/pro.757","article-title":"Signal Peptidase I: Cleaving the Way to Mature Proteins","volume":"21","author":"Auclair","year":"2012","journal-title":"Protein Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1124\/pr.119.018762","article-title":"Monocarboxylate Transporters (Slc16): Function, Regulation, and Role in Health and Disease","volume":"72","author":"Felmlee","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/me.2001-0309","article-title":"Identification of a Novel Human Organic Anion Transporting Polypeptide as a High Affinity Thyroxine Transporter","volume":"16","author":"Pizzagalli","year":"2002","journal-title":"Mol Endocrinol (Baltimore Md)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B","article-title":"Caco-2 Cells Express a Combination of Colonocyte and Enterocyte Phenotypes","volume":"174","author":"Engle","year":"1998","journal-title":"J Cell Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015937605100","article-title":"Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa","volume":"7","author":"Hilgers","year":"1990","journal-title":"Pharm Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.664839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T06:57:04Z","timestamp":1622012224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.664839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":42,"alternative-id":["10.3389\/fendo.2021.664839"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.664839","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"article-number":"664839"}}